Connection

ROBERT DANTZER to Adult

This is a "connection" page, showing publications ROBERT DANTZER has written about Adult.
Connection Strength

0.165
  1. An effort expenditure perspective on cancer-related fatigue. Psychoneuroendocrinology. 2018 10; 96:109-117.
    View in: PubMed
    Score: 0.025
  2. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun. 2015 May; 46:55-9.
    View in: PubMed
    Score: 0.019
  3. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology. 2015 Jan; 40(2):463-71.
    View in: PubMed
    Score: 0.019
  4. Salivary biomarkers of stress: cortisol and alpha-amylase. Psychoneuroendocrinology. 2009 Jan; 34(1):1.
    View in: PubMed
    Score: 0.013
  5. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial. Lancet Oncol. 2024 May; 25(5):658-667.
    View in: PubMed
    Score: 0.009
  6. Cancer exosomes induce tumor innervation. Nat Commun. 2018 10 16; 9(1):4284.
    View in: PubMed
    Score: 0.006
  7. Functional TSPO polymorphism predicts variance in the diurnal cortisol rhythm in bipolar disorder. Psychoneuroendocrinology. 2018 03; 89:194-202.
    View in: PubMed
    Score: 0.006
  8. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression. Brain Behav Immun. 2018 Jan; 67:59-64.
    View in: PubMed
    Score: 0.006
  9. Sleep disturbance and kynurenine metabolism in depression. J Psychosom Res. 2017 08; 99:1-7.
    View in: PubMed
    Score: 0.006
  10. Serum kynurenic acid is reduced in affective psychosis. Transl Psychiatry. 2017 05 02; 7(5):e1115.
    View in: PubMed
    Score: 0.006
  11. Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial. Neuropsychopharmacology. 2017 Mar; 42(4):801-810.
    View in: PubMed
    Score: 0.005
  12. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain Behav Immun. 2016 Aug; 56:335-42.
    View in: PubMed
    Score: 0.005
  13. [Stress theories and the somatization process]. Encephale. 1995 Dec; 21 Spec No 7:3-9.
    View in: PubMed
    Score: 0.005
  14. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain Behav Immun. 2016 Mar; 53:39-48.
    View in: PubMed
    Score: 0.005
  15. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder. Psychoneuroendocrinology. 2015 Dec; 62:54-8.
    View in: PubMed
    Score: 0.005
  16. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology. 2015 Feb; 52:200-11.
    View in: PubMed
    Score: 0.005
  17. Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? PLoS One. 2014; 9(1):e85945.
    View in: PubMed
    Score: 0.005
  18. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry. 2010 Apr; 15(4):393-403.
    View in: PubMed
    Score: 0.003
  19. Affective components of the human-animal relationship in animal husbandry: development and validation of a questionnaire. Psychol Rep. 2004 Aug; 95(1):275-90.
    View in: PubMed
    Score: 0.002
  20. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry. 2002; 7(5):468-73.
    View in: PubMed
    Score: 0.002
  21. Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med. 2001 May-Jun; 63(3):376-86.
    View in: PubMed
    Score: 0.002
  22. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology. 2001 Feb; 24(2):130-40.
    View in: PubMed
    Score: 0.002
  23. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol. 2000 May; 18(10):2143-51.
    View in: PubMed
    Score: 0.002
  24. Attentional and mnemonic deficits associated with infectious disease in humans. Psychol Med. 1999 Mar; 29(2):291-7.
    View in: PubMed
    Score: 0.002
  25. Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J Clin Invest. 1992 Feb; 89(2):451-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.